The opioid receptor-like 1 receptor (ORL 1 ), an orphan receptor whose human and murine complementary DNAs, has been characterized recently. ORL 1 transcripts are particularly abundant in the central nervous system. We demonstrated that ORL 1 expressed in human neuroblastoma SK-N-SH and SH-SY5Y cell lines by radioligand binding assay, reverse transcription polymerase chain reaction (RT-PCR) and Northern analysis in the present study. Stimulation with ORL 1 specific agonist, nociceptin/orphanin FQ, increased [
INTRODUCTION
Opioid acts in the central and peripheral nervous system (CNS and PNS) to produce numerous pharmacological effects. Repetitive or continuous use of opioids, however, causes drug tolerance and dependence. Three subtypes of opioid receptors, termed μ, δ , and κ , have been cloned. They are coupled to the inhibitory G protein and negatively regulate adenylyl cyclase [1] . Recently a new G-proteincoupled receptor termed opioid receptor-like receptor (ORL 1 ) which belongs to the newly characterized opioid receptor subfamily had been cloned from human brainstem cDNA libraries [2] [3] [4] [5] [6] [7] [8] . Its endogenous specific agonist N/OFQ has also been identified [9, 10] , and it expresses mainly in the CNS [1, 4, 6, 7] . In spite of the fact that ORL 1 shares over 50 % homology with opioid receptors, it has very low affinity for the opioid ligands [5] . N/OFQ treatment causes inhibition of forskolin-stimulated cAMP accumulation in Chinese hamster ovary (CHO) cells exogenously transfected with ORL 1 cDNA [9, 10] , stimulation of [
35 S]GTP-γS binding in rat brain [ll] and increase of inwardly rectifying K + conductance in rat dorsal raphe nucleus neurons [12] . However, the information on signal transduction mediated by ORL 1 in a neuronal cellular system is lacking. In the present study, we have demonstrated that both human neuroblastoma SK-N-SH cells, which express the μ and δ opioid receptors [13] , and SH-SY5Y cells also endogenously express ORL 1 , and that stimulation of SK-N-SH cells with N/OFQ, a specific ligand of ORL 1 , leads to activation of inhibitory G-proteins.
MATERIALS AND METHODS

Cell lines and cell culture
Human neuroblastoma SK-N-SH cells (American Type Culture Collection) were cultured in RPMI 1640 (Gibeo-BRL) supplemented with 10% heat-inactivated fetal calf serum (Evergreen, Hangzhou, China). Chinese Hamster Ovary (CHO) cells and CHO:hORL 1 cells were cultured in DMEM (Gibco-BRL) containing 10% heat-inactivated calf serum (Evergreen). Human neuroblastoma SH-SY5Y cells were cultured in MEM (Gibco-BRL) containing 15% heat-inactivated fetal calf serum (Gibco-BRL). The media were also supplemented with 100 units/ml penicillin, 100 μg/ml streptomycin.
Isolation of total RNA
2 × 10 6 cultured cells were collected by centrifugation and lysed in 1 ml of TRIzol Reagent (Gibco-BRL) by repetitive pipetting. Total RNA was extracted according to the manufacturerprovided protocols from cultured cells and dissolved in diethypyrocarbonate (DEPC) treated water.
Reverse transcription polymerase chain reaction (RT-PCR)
First-strand cDNA was made from total RNA by using Superscript preamplifiaction system (Gibco-BRL) and following the procedures suggested by the manufacturer. 2 μg of total RNA was heated to 70℃ for 10 min in 11 μl of DEPC-treated water containing 0.5 μg of oligo(dT) [12] [13] [14] [15] [16] [17] [18] . 4 μl of 5 × synthesis Buffer [250 mM Tris-HCl (pH 8.3), 375 mM KCl, 15 mv MgCl 2 ], 1 μl of 10 mM dNTP mix, 2 μl of 0.1 M DTT, 1 μl of RNasin (20U/μl) and 1 μl of reverse transcriptase (SuperScript II RT; 200U/μl) were added to the sample. The reaction mixture was incubated at room temperature for 10 min and subsequently at 42 ℃ for 50 min. The reaction was terminated by incubating the mixture at 70 ℃ for 10 min. After cooling on ice for 10 min, 1 μl of RNase H (2U/μl) was added to the mixture and then incubated for 20 min at 37 ℃.
PCR primers used were ORL 1 FBamH and ORL 1 REcoR. These two primers correspond to regions from bases 171 to 188 and 1293 to 1310 on human ORL 1 cDNA [2] respectively. The other pair of primers, ORT5 (GGCACGGACATCCTCCTGGGCTTC) and ORT3 (GGGATCTC-CACCAGGCACTCGATC) correspond to regions from bases 497 to 515 and 766 to 784 respectively. The PCR reactions (50 μl) contained 5 μl of first-strand cDNA, 2 units of Taq polymerase (Promega). The conditions used were: 94 ℃ 1 min; 60 ℃ for 1 min; 72 ℃ for 1.5 rain. This cycle was repeated 30 times. The PCR products (1150 bp and 300 bp respectively) were analyzed on a 1% agarose gel.
Cloning of human ORL 1 cDNA by polymerase chain reaction PCR primers used were ORL 1 FBamH (CGCGGATCC AGTGGCATGGAGCCC CTCTTCCC) and ORL 1 REcoR (CAGGAATTC CATGGGCAGGTCCACGCCTAGTC). These primers are designed according to the sequence reported previously [2] with the restriction sites underlined and synthesized by GENOSYS. The reaction (50 μl) contained 10 ng of human Brain cDNA (Clontech Laboratories), 2 units of Taq polymerase (Promega). The PCR conditions were just like above. PCR products were purified from a 1% agarose gel using QIAEX Gel Extraction Kit, digested with BamH I and EcoR I, and subcloned into pcDNA 3 (Invitrogen). This BamH I and EcoR I fragment containing the entire coding region of human ORL 1 . Nucleotide sequence analysis was performed using the Sequenase 2.0 DNA sequencing kit (Amersham) according to the manufacturer-suggested protocol.
Northern blot analysis
Total RNA of each sample was electrophoresed on a 1% agarose-glyoxal gel (20 μg/lane), transferred onto a nylon membrane (Amersham) with 20 × SSC (1 × SSC is 0.15 M Sodium Chloride, 0.15 M Sodium Citrate, pH 7.0). Then the membrane was exposed to UV light using a GS Gene Linker (Bio-Rad).
Gene-specific probe was prepared from cloned pcDNA 3 :hORL 1 .The plasmid was digested with BamH I and EcoR I. The 1150 bp restriction fragment containing entire coding region of ORL 1 was purified using QIAEX Gel Extraction Kit (QIAEX).
32 P-labeled random-primed probe was made to a specific activity of 5 × 10 8 dpm/μg DNA using the Ready To Go DNA Labeling Kit (Pharmacia Biotech). The membrane was perhybridized in 0.5 M phosphate buffer (pH 7.2), 7% SDS (Sodium Dodecyl Sulfate), 1 mM EDTA for 2 h at 65 ℃, and hybridized to 32 P-labeled probe for 20 h at 65 ℃[14].
The membrane was washed twice in 2 × SSC/0.1% SDS at room temperature for 15 min each, and then twice in 0.5 × SSC/0.1% SDS at 55 ℃ for 15 min each. The membrane was exposed to X-ray film (Kodak) for 24 -72 h.
Construction of CHO:hORL 1 stable cell line
CHO cells grown in 60 mm dishes were transfected with 10 μg/dish of pcDNA3:hORL 1 by calcium phosphate precipitation [15] . 24 h after transfection, the cells were treated with trypsin and diluted 1:10. The following day, selection of transfectants was initiated by addition of 1 mg/ml Geneticin (Gibco-BRL). Two weeks later, individual resistant clones were isolated, cultured separately and checked for the presence of hORL 1 transcripts by using saturation binding [16] with 
S]GTPγS binding assay
The experiments were performed as described previously [11] . Cells were lysed in buffer contain-ing 5 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 5 mM EGTA and the cell lysate was centrifuged at 30,000 × g for 10 min. The membranes (containing 15 μg protein) were incubated in 50 mM TrisHCl, pH 7.5, 5 mM MgCl 2 , 1 mM EGTA, 100 mM NaCl, 40 μM GDP, and 8 nM [
35 S]GTPγS (1200 Ci/mmol, DuPont-New England Nuclear), in a total volume of 0.1 ml. The incubation was started by adding the membrane suspension to the reaction mixture and was carried out at 37 ℃ for 1 h. The reaction was terminated by diluting in phosphate buffered saline and filtered through GF/C filters under vacuum. Bound radioactivity was determined by liquid scintillation spectrophotometry. Basal binding was assessed in the absence of agonist and non-specific binding was determined in the presence of 10 μM GTPγS. 
Cyclic AMP assay and receptor desensitization
Cells were challenged with N/OFQ or DPDPE in the presence of 1 μM forskolin and 500 μM 1-methyl-3-isobutylxantine (IBMX, Sigma) at 37 ℃ for 10 min. The reactions were terminated with 1 N perchloric acid and neutralized with 2N K 2 CO 3 . The cAMP level of each sample was determined using radioimmunoassay as described previously [17] . Data were averages from triplicate samples and presented as percentage of control (in the presence of forskolin alone). 
Measurement of extracellular metabolic rates
Extracellular metabolic rates were measured with the silicon-based light addressable potentiometer Cytosensor Microphysiometer (Molecular Devices Corp., CA, USA). CHO:hORL 1 cells was seeded at 1 × 10 5 cells/capsule cups (Molecular Devices Corp.), and cultured overnight after the cells adhered to the capsule membrane. A spacer gasket and capsule insert (Molecular Devices Corp.) were placed into each capsule cup. The assembled capsule cups were loaded into Cytosensor Chambers. Low buffering and carbonate-free DMEM (Gibco-BRL) was used as medium in the Cytosensor, and the extracellular acidification rates were monitored, collecting a rate measurement every 90 sec. Cells were exposed to N/OFQ in running medium (0.1 ml/min) for 335 sec, and the effects on the extracellular acidification rate were measured by the instrument. The basal acidification rate was normalized to 100 %.
RESULTS AND DISCUSSION
Endogenous expression of ORL 1 in human neuroblastoma cells
In situ hybridization and immunohistochemistry studies revealed that ORL 1 and its endogenous ligand N/OFQ express widely over the brain [3, 4, 6, 9, 18, 19] . ORL 1 receptor transcripts are present in the CNS, including the hypothalamus, brainstem and spinal cord dorsal horn [l, 7, 8] as well as in a few peripheral organs such as intestine, vas deferens and spleen [6] . It suggests that ORL 1 plays a role in many central processes, including learning and memory. However, the endogenous expression of ORL 1 in any cell line has not been reported. Therefore, we examined several neuronal cell lines for the expression of ORL 1 . To detect ORL 1 receptor mRNA sensitively, we assessed the level of ORL 1 transcriptsits with RT-PCR. As shown in Fig 1A, with the primer sets of ORL 1 FBamH/ORL 1 REcoR and ORT5/ORT3, PCR products of expected sizes (1150 bp and 300 bp) were obtained, using cDNA reverse transcripts from total RNA extracted from SH-SY5Y, or SK-N-SH cells. The PCR products were cloned, sequenced and confirmed as human ORL 1 cDNA. PCR reaction using cDNAs from CHO cells or genomic DNA from SK-N-SH cells as control template failed to produce any detectable PCR product. This result indicates the expression of ORL 1 in both human neuroblastoma cell lines (SH-SY5Y and SK-N-SH) tested. Furthermore, Northern analysis showed that a RNA species of 3.7 kb from SK-N-SH cells hybridized to the ORL 1 cDNA probe, confirming the expression of ORL 1 in SK-N-SH cells (Fig 1B, lane 1) . We demonstrated the presence of ORL 1 in SK-N-SH cells using radioligand saturation experiment. Our results showed that [ 3 H]N/OFQ binds to the cell membranes from human neuroblastoma SK-N-SH cells specifically in a dose-dependent and saturable manner (data not shown). The above results clearly indicate that ORL 1 protein is expressed on the surface of neuroblastoma SK-N-SH cells. Our observation of the presence of ORL 1 in SH-SY5Y cells was independently confirmed by Houtani et al recently[20] .
ORL 1 -mediated signal transduction in SK-N-SH cells
Activation of opioid receptors results in inhibition sof adenylyl cyclase via activation of inhibitory G proteins. The ability for N/OFQ to attenuate cellular cAMP production has been demonstrated in CHO cells exogenously expressing ORL 1 [9, 10] . N/OFQ-stimulated activation of G proteins has also been shown in rat brain [11] . However, the inhibition of adenylyl cyclase activity mediated by ORL 1 has not been observed in neuronal cells and the signal transduction processes mediated by ORL 1 have not been systematically examined in a neuronal cellular environment. We have observed that SK-N-SH cells endogenously express ORL 1 . Therefore, we took on to determine the activation of the inhibitory G-protein stimulated by N/OFQ in SK-N-SH cells, using decrease of forskolin-stimulated accumulation of cAMP (EC 50 = 0.80 ± 0.45 nM ), indicative of functionally negative coupling of ORL 1 to adenylyl cyclase in the neuronal cells (Fig 2B) . The above data indicate that ORL 1 is functionally expressed in SK-N-SH cells.
ORL 1 -mediated changes in the metabolic rates of CHO:hORL 1 cells
In the above experiments, we have demonstrated, using human neuroblastoma cell line SK-N-SH, that endogenous ORL 1 mediates activation of G proteins and inactivation of adenylyl cyclase. Activation of ORL 1 receptor by N/OFQ was also accessed using microphysiometer.
Cytosensor microphysiometer measures the proton excretion of cells accurately in real time. Proton excretion, or extracellular acidification, depends largely on the energy consumption of a cell. When cell surface receptors are triggered by ligands, the cellular metabolism is activated by second messenger pathways resulting in increased energy metabolism and extracellular acidification which can be measured by microphysiometer.
To access cellular response to N/OFQ in real time scale by microphysiometry, a cell line stably expressed human ORL 1 was estabolished. Human ORL 1 cDNA was cloned into expression vector pcDNA 3 and transfected into CHO ceils. Transfected CHO cells stably expressing ORL 1 receptors were selected. A cell line CHO:hORL 1 with high expression of ORL 1 was selected and used in the following experiments. As detected in the Northern analysis, a RNA species at approximately 1.8 kb from the CHO:hORL 1 cell line strongly hybridized to the ORL 1 cDNA probe, indicating that the CHO:hORL 1 cell line exprssed ORL 1 mRNA transcripts at high level. No hybridization signal was detected in untransfected CHO cells (Fig 1B) .
Functional responses in CHO:hORL 1 cells was studied using a microphysiometer. Fig 3 shows the changes in extracellular acidification rates in CHO:hORL 1 cells upon application of various concentrations of ORL 1 -specific agonist N/OFQ. Infusion of N/OFQ into the chambers containing CHO:hORL 1 cells expressing N/OFQ receptors lead to a rapid increase in the extracellular acidification rate (Fig 3) . The effect of N/OFQ on the extracellular acidification rate measured in the microphysiometer was found to be concentration dependent. The cellular response to N/OFQ occurred at 100 pmol/L concentration of N/OFQ and reached maximum at 10 nmol/L. The increase in metabolic rate stimulated by ORL 1 ligand peaked at approximately 150 % of the unstimulated rate. Pertussis toxin, a specific inhibitor of Gi/Go proteins, completely blocked the cellular response to N/OFQ (data not shown).
In summary, we have demonstrated that ORL 1 is functionally expressed in human neuroblastoma SK-N-SH cells. RT-RCR and Northern analysis indicate the presence of ORL 1 transcripts in SK-N-SH and SH-SY5Y cells. Treatement of the cells with N/OFQ, the specific ligand of ORL 1 , resulted in a increase in the extracellular acidification rate in a concentration-dependent manner.
